Parallel Advisors’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Parallel Advisors's TWST Position: Q2 2026 in Review
Parallel Advisors increased its Twist Bioscience (TWST) stake by 92% in Q2 2026, buying an estimated $3.58K and bringing the position to 115 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2868.
Parallel Advisors first reported a position in TWST in Q1 2020 and has held it in 24 quarters since. The position peaked at $14K in Q2 2020. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Parallel Advisors held 115 shares of Twist Bioscience worth $11.8K as of Q2 2026.
- Parallel Advisors bought 55 Twist Bioscience shares in Q2 2026, an estimated $3.58K.
- Twist Bioscience made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2868 holding.
- Parallel Advisors first reported a position in Twist Bioscience in Q1 2020 and has held it in 24 quarters since.
- Parallel Advisors's Twist Bioscience position peaked at $14K in Q2 2020.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.